Global and United States Drug Safety and Pharmacovigilance Software Market Report & Forecast 2022-2028

Drug Safety and Pharmacovigilance Software is scientific research software that discovers, evaluates, understands and prevents adverse reactions or any other problems that may be related to drugs.
Market Analysis and Insights: Global and United States Drug Safety and Pharmacovigilance Software Market
This report focuses on global and United States Drug Safety and Pharmacovigilance Software market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Drug Safety and Pharmacovigilance Software market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, ADR Reporting accounting for % of the Drug Safety and Pharmacovigilance Software global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Pharma & Biotech Companies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Pharmacovigilance involves not only the adverse reactions of drugs, but also other problems related to drugs, such as substandard drugs, drug treatment errors, lack of effectiveness reports, the use of medicines for indications that are not recognized without sufficient scientific evidence, acute and chronic Case reports of poisoning, evaluation of drug-related mortality, misuse and misuse of drugs, adverse interactions between drugs and chemical drugs, other drugs and food.
Global Drug Safety and Pharmacovigilance Software Scope and Market Size
Drug Safety and Pharmacovigilance Software market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Drug Safety and Pharmacovigilance Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Drug Safety and Pharmacovigilance Software market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
ADR Reporting
Drug Safety Audits
Issue Tracking
Fully Integrated Software
Segment by Application
Pharma & Biotech Companies
CROs
BPOs
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AB cube
Max Application
Ennov Solutions Inc
ArisGlobal
EXTEDO GmbH
Online Business Applications Inc
Oracle Corporation
Sparta Systems, Inc.
United BioSource Corporation
Sarjen Systems